Mining free compound databases to identify candidates selected by virtual screening

Expert Opinion on Drug Discovery

Volumn 4, Issue 9, 2009, Pages 901-906

  Vasudevan, Sridhar R ^a   Churchill, Grant C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Calcium; Chemical probe; In silico; Ligand based; NAADP; Second messenger; Shape based; Virtual screening

Indexed keywords

LIGAND; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE;

COMPUTER PROGRAM; DATA BASE; HIGH THROUGHPUT SCREENING; MOLECULAR BIOLOGY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EID: 70249148040     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440903190953     Document Type: Review

References (30)

1. Kaiser J. Molecular biology. Industrial-style screening meets academic biology. Science 2008;321:764-766
2. Inglese J, Johnson RL, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007;3:466-479 (Pubitemid 47080373)
3. Naylor E, Arredouani A, Vasudevan SR, et al. Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol 2009;5:220-226
4. Lee HC. Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling. J Biol Chem 2005;280:33693-33696 (Pubitemid 41443085)
5. Churchill GC, Okada Y, Thomas JM, et al. NAADP mobilizes Ca2+ from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 2002;111:703-708 (Pubitemid 35441251)
6. Cancela JM, Churchill GC, Galione A. Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature 1999;398:74-76 (Pubitemid 29124470)
7. Black J. A personal view of pharmacology. Annu Rev Pharmacol Toxicol 1996;36:1-33
8. Walseth TF, Lee HC. Pharmacology of cyclic ADP-ribose and NAADP. In: Lee HC, editor, Cylcic ADP-ribose and NAADP: structures, metabolism and functions. Kluwer Academic Publishers; 2002. p. 121-141
9. Lee HC, Aarhus R. Structural determinants of nicotinic acid adenine dinucleotide phosphate important for its calcium-mobilizing activity. J Biol Chem 1997;272:20378-20383 (Pubitemid 27355587)
10. Parkesh R, Lewis AM, Aley PK, et al. Cell-permeant NAADP: a novel chemical tool enabling the study of Ca2+ signalling in intact cells. Cell Calcium 2007;43:531-538
11. Lee HC, Aarhus R, Gee KR, et al. Caged nicotinic acid adenine dinucleotide phosphate. Synthesis and use. J Biol Chem 1997;272:4172-4178 (Pubitemid 27078484)
12. Churchill GC, Galione A. NAADP induces Ca2+ oscillations via a two-pool mechanism by priming IP3- and cADPR-sensitive Ca2+ stores. EMBO J 2001;20:2666-2671
13. Dowden J, Berridge G, Moreau C, et al. Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release. Chem Biol 2006;13:659-665 (Pubitemid 43912459)
14. Capdeville R, Buchdunger E, Zimmermann J, et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 2002;1:493-502
15. Billington RA, Bak J, Martinez-Coscolla A, et al. Triazine dyes are agonists of the NAADP receptor. Br J Pharmacol 2004;142:1241-1246 (Pubitemid 39178877)
16. Billington RA, Genazzani AA. PPADS is a reversible competitive antagonist of the NAADP receptor. Cell Calcium 2007;41:505-511
17. Genazzani AA, Mezna M, Dickey DM, et al. Pharmacological properties of the Ca2+-release mechanism sensitive to NAADP in the sea urchin egg. Br J Pharmacol 1997;121:1489-1495 (Pubitemid 27317565)
18. Oprea TI, Matter H. Integrating virtual screening in lead discovery. Curr Opin Chem Biol 2004;8:349-358 (Pubitemid 38996798)
19. Shoichet BK. Virtual screening of chemical libraries. Nature 2004;432:862-865
20. Payne DJ, Gwynn MN, Holmes DJ, et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007;6:29-40
21. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006;5:993-996
22. Available from: http://nihroadmap.nih.gov/molecularlibraries/
23. Rush TS 3rd, Grant JA, Mosyak L, et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J Med Chem 2005;48:1489-1495 •• First report of using a three-dimensional shape comparison program (ROCS) to achieve dramatic scaffold hops.
24. Muchmore SW, Souers AJ, Akritopoulou-Zanze I. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist. Chem Biol Drug Des 2006;67:174-176 (Pubitemid 43881377)
25. Jenkins JL, Glick M, Davies JW. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. J Med Chem 2004;47:6144-6159 •• A retrospective study showing that three-dimensional similarity can be used to scaffold hop from endogenous ligands to drug-like molecules. (Pubitemid 39587240)
26. Ballester PJ, Finn PW, Richards WG. Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology. J Mol Graph Model 2009;27:836-845
27. Calcraft PJ, Ruas M, Pan Z, et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 2009;459:596-600
28. Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177-182
29. Nettles JH, Jenkins JL, Williams C, et al. Flexible 3D pharmacophores as descriptors of dynamic biological space. J Mol Graph Model 2007;26:622-633 (Pubitemid 47500212)
30. Kolb P, Rosenbaum DM, Irwin JJ, et al. Structure-based discovery of beta2-adrenergic receptor ligands. Proc Natl Acad Sci USA 2009;106:6843-8 • A prospective study illustrating the potential power of docking by identifying 6 active compounds out of 25 tested including the most potent inverse agonist known for an 'old' target.